Reporting time-to-event endpoints and re
✍
Hendrik-Tobias Arkenau; Ina Nordman; Timothy Dobbins; Robyn Ward
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 244 KB
## Abstract ## BACKGROUND: Reporting of randomized controlled clinical trials (RCTs) often is suboptimal. Cancer drug trials are complicated further by multiple survival and response endpoints. The authors of this report determined the frequency of reporting of time‐to‐event endpoints and tumor re